Reevaluation Of Systemic Early Neuromuscular Blockade

Trial ID or NCT#

NCT02509078

Status

not recruiting iconNOT RECRUITING

Purpose

This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a patient with acute respiratory distress syndrome will improve survival. Half of the patients will receive a neuromuscular blocker for two days and in the other half the use of neuromuscular blockers will be discouraged.

Official Title

Reevaluation Of Systemic Early Neuromuscular Blockade

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Joseph Levitt, MD, MS
Joseph Levitt, MD, MS
Pulmonary critical care specialist, Pulmonologist, Critical care specialist
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Matthew Strehlow
Matthew Strehlow
Emergency medicine doctor
Professor of Emergency Medicine (Adult Clinical/Academic)

Contact us to find out if this trial is right for you.

Contact

SPECTRUM
6507236576

View on ClinicalTrials.gov